Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 59
Filter
2.
Paediatr Anaesth ; 11(5): 567-73, 2001.
Article in English | MEDLINE | ID: mdl-11696121

ABSTRACT

BACKGROUND: In this prospective, cohort study of 15 children (median age 7.7 years, range 4.9-16.5 years) undergoing atrial septal defect repair, we evaluated changes in the Bispectral index (BIS) as a potential monitor of level of consciousness during cardiac anaesthesia. METHODS: Identical cardiac surgery, cardiopulmonary bypass (CPB) and anaesthetic techniques were used, including mild hypothermia and an early extubation protocol. BIS, mean arterial pressure, heart rate and tympanic temperature were recorded at baseline postinduction (Tbaseline), skin incision (Tincis), sternotomy (Tsternot), aortic cannulation (Tcann), nadir temperature (Tnadir), rewarmed (Trewarmed), immediate post-CPB (TpostCPB), chest drain insertion (Tdrains), sternal wires (Twire), skin closure (Tclosed) and spontaneous movement (Tmove). As a measure of stress response, serum lactate, glucose, norepinephrine and epinephrine levels were measured at Tbaseline, Tsternot, Tcann, Tnadir, Trewarmed and Tdrains. Explicit memory testing was undertaken prior to hospital discharge. RESULTS: BIS increased significantly during the rewarming phase (Trewarmed versus Tbaseline and Tnadir, P<0.001). Lactate, epinephrine and glucose levels were also significantly elevated at Trewarmed. There were no correlations between BIS and the increase in epinephrine, lactate and glucose during rewarming, nor with changes in heart rate or mean arterial pressure during surgery. All patients had an uneventful recovery without evidence for explicit recall. CONCLUSIONS: The increase in BIS during the rewarming phase could reflect an increase in conscious level, and is consistent with the reported risk for awareness during this phase of cardiac surgery.


Subject(s)
Cardiopulmonary Bypass , Electroencephalography/methods , Heart Septal Defects, Atrial/surgery , Monitoring, Intraoperative/methods , Adolescent , Blood Pressure , Child , Child, Preschool , Cohort Studies , Epinephrine/metabolism , Glucose/metabolism , Heart Rate , Humans , Hypothermia, Induced , Lactic Acid/metabolism , Norepinephrine/metabolism , Prospective Studies , Time Factors
3.
Paediatr Anaesth ; 11(6): 663-9, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11696141

ABSTRACT

BACKGROUND: We evaluated the relationship of the bispectral index (BIS) to commonly used indices of depth of anaesthesia in 19 infants enrolled in a prospective study of the stress response to hypothermic cardiopulmonary bypass. METHODS: Group 1 (n=8) received high-dose fentanyl by bolus technique; group 2 (n=6) received high-dose fentanyl by continuous infusion; and group 3 (n=5) received a fentanyl-midazolam infusion. Blood pressure (BP), heart rate (HR) and plasma epinephrine, norepinephrine, cortisol, ACTH, glucose, lactate and fentanyl were analysed 15 min postinduction, 15 min poststernotomy, 15 min on CPB during cooling and during skin closure. RESULTS: Mean BIS (SD) values for all 19 patients were 45.3 (12.3), 40.4 (14.5), 24.4 (12.4) and 47.9 (13.9), at the successive time points. No significant differences were observed in changes in BIS over time between the groups. A significant correlation was found 15 min postinduction between BIS and BP (systolic r=0.51, mean r=0.56) in all groups, but not between BIS and HR. BIS did not correlate with BP or HR at any other time point. There was no significant correlation between BIS and hormonal, biochemical or plasma fentanyl levels for any group at any time point. CONCLUSIONS: We were unable to demonstrate a relationship between the BIS and haemodynamic, metabolic or hormonal indices of anaesthetic depth. Further evaluation of the BIS algorithm is required in neonates and infants.


Subject(s)
Anesthetics, Intravenous/blood , Cardiac Surgical Procedures , Electroencephalography , Fentanyl/blood , Stress, Physiological/physiopathology , Anesthetics, Intravenous/administration & dosage , Biomarkers , Cardiopulmonary Bypass , Double-Blind Method , Female , Fentanyl/administration & dosage , Hemodynamics/physiology , Hormones/blood , Humans , Hypothermia, Induced , Infant , Infant, Newborn , Infusions, Intravenous , Male , Monitoring, Intraoperative , Prospective Studies
4.
Cornea ; 20(8): 802-6, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11685055

ABSTRACT

PURPOSE: To determine the efficacy and safety of topical autologous serum as a treatment of dry eye patients. METHODS: A 2-month, prospective, single-masked, placebo-controlled study was conducted in patients with bilateral severe dry eye. One eye was randomized to receive the patient's own serum as a tear substitute, and the fellow eye received unpreserved normal saline solution as a placebo. Subjective symptoms and clinical parameters of dry eye including conjunctival impression cytology were assessed at baseline and 1 week, 1 month, and 2 months after treatment. RESULTS: Twelve dry eye patients were enrolled. Both subjective symptoms (discomfort, foreign-body sensation, dryness, and photophobia), objective signs (fluorescein and rose bengal staining and conjunctival impression cytology) improved significantly in treated eyes compared with baseline. Control eyes also had improvement in symptoms, signs, and rose bengal staining compared with baseline. Neither Schirmer test results nor tear break-up time improved in either group. The means score of all parameters were improved in both groups, and the results of conjunctival impression cytology were better in treated eyes; however, these results are not significantly different. There were no serious adverse effects observed in this study. CONCLUSIONS: There was a trend toward improvement in symptoms and signs of dry eye including cytologic changes after application of autologous serum in severe dry eye patients. However, this trend was not statistically significant. A larger scale study is warranted.


Subject(s)
Blood , Dry Eye Syndromes/therapy , Administration, Topical , Adult , Aged , Dry Eye Syndromes/physiopathology , Female , Humans , Male , Middle Aged , Prospective Studies , Safety , Single-Blind Method , Treatment Outcome
5.
Br J Anaesth ; 86(2): 223-9, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11573664

ABSTRACT

The pharmacokinetics and time course of action of vecuronium in normal children and children receiving anticonvulsant drugs for prolonged periods were characterized. A bolus dose of vecuronium 0.15 mg kg(-1) was administered i.v. to 10 non-epileptic children and to 10 children on phenytoin and 10 children on carbamazepine, who were matched for age and weight. Plasma concentrations of vecuronium, 3-OH desacetylvecuronium (the primary metabolite of vecuronium) and alpha1-acid glycoprotein (AAG) were determined. Pharmacokinetic variables were derived from plasma samples collected before and after administration of vecuronium. Neuromuscular transmission was monitored by evoked compound electromyography. Recovery of the first twitch of the train-of-four (T1/T0) and the recovery index (RI), the time for 25-75% recovery of T1/T0, were determined. The elimination half-life of vecuronium was significantly reduced in both anticonvulsant groups compared with control [control 48.2 (SD 40.3), phenytoin 23.5 (13.1), carbamazepine 18.4 (16.6) min, P<0.05]. Vecuronium clearance was increased in both anticonvulsant groups [control 9.0 (3.6), phenytoin 15.1 (8.9), carbamazepine 18.8 (13.1) ml kg(-1) min(-1), 0.05

Subject(s)
Anticonvulsants/pharmacology , Carbamazepine/pharmacology , Neuromuscular Nondepolarizing Agents/pharmacology , Phenytoin/pharmacology , Vecuronium Bromide/pharmacology , Adolescent , Anesthesia, General , Anticonvulsants/blood , Child , Child, Preschool , Drug Interactions , Drug Resistance , Electromyography/drug effects , Female , Half-Life , Humans , Male , Neuromuscular Junction/drug effects , Neuromuscular Junction/physiology , Neuromuscular Nondepolarizing Agents/blood , Orosomucoid/metabolism , Vecuronium Bromide/blood
6.
Anesth Analg ; 93(2): 326-30, 2nd contents page, 2001 08.
Article in English | MEDLINE | ID: mdl-11473853

ABSTRACT

UNLABELLED: The bispectral index (BIS) correlates with consciousness during adult anesthesia. In this prospective, blinded study of children (n = 24) and infants (n = 25) undergoing elective circumcision, we evaluated BIS and consciousness level during emergence from anesthesia. Anesthesia was maintained with sevoflurane, and a penile nerve block was performed in each patient before surgical stimulation. At the completion of surgery, the sevoflurane was decreased stepwise from 0.9% in increments of 0.2%, and arousal was tested with a uniform auditory stimulus given after a steady state of end-tidal sevoflurane concentration was achieved at each step. The BIS increased significantly as the sevoflurane concentrations decreased in children (0.9%, 62.5 +/- 8.1; 0.7%, 70.8 +/- 7.4; and 0.5%, 74.1 +/- 7.1; P < 0.001 for 0.7% and 0.5% compared with 0.9%), but a similar relationship was not demonstrated in infants. The BIS values at 0.7% and 0.5% sevoflurane were significantly higher in children than infants (P < 0.02 and P < 0.002, respectively). In both children and infants, the BIS increased significantly from pre- to postarousal (children, 73.5 +/- 7 to 83.1 +/- 12, P = 0.01; infants, 67.8 +/- 10 to 85.6 +/- 13.6, P < 0.001). The BIS at which arousal was possible with the stimulus tended to be higher in children than in infants (P = 0.06). IMPLICATIONS: In this study comparing the Bispectral index (BIS) in infants and children undergoing circumcision surgery by use of a standardized surgical and anesthetic technique, a significant decrease in BIS was detected in children during a stepwise decrease in end-tidal sevoflurane concentration. A similar relationship was not demonstrated in infants less than 1 yr old. In both children and infants, BIS increased significantly from pre- to postarousal. Additional studies are necessary to determine changes in BIS with maturational changes in the electroencephalogram.


Subject(s)
Anesthesia , Circumcision, Male , Electroencephalography , Adolescent , Child , Child, Preschool , Humans , Infant , Male , Prospective Studies
7.
Anesth Analg ; 91(1): 11-5, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10866879

ABSTRACT

UNLABELLED: We evaluated the efficacy of ketorolac in suppressing postoperative bladder spasms after ureteroneocystostomy (ureteral reimplantation). Twenty-four pediatric patients undergoing intravesical ureteroneocystostomy were enrolled prospectively to receive either ketorolac or placebo via double-blinded randomization. Twelve patients in each group shared similar preoperative characteristics. All were maintained on an epidural infusion of bupivacaine (0.1%) with fentanyl (2 microg/mL) throughout the study. Patients were given either ketorolac (0.5 mg. kg(-1). dose(-1)) or placebo (equivalent volume saline) IV after surgery and every 6 h thereafter for 48 h. Parents were instructed to record bladder spasm episodes prospectively by using a standardized time-flow diary. Three patients (25%) in the ketorolac group experienced bladder spasms, compared with 10 patients (83%) in the placebo group (two-sided P < 0.05). The median severity score for the ketorolac group was 1.2 (mild = 1.0, severe = 3.0), compared with 2.6 for the placebo group (P = 0.003). We conclude that IV ketorolac reduces the frequency and severity of postoperative bladder spasms after intravesical ureteroneocystostomy. IMPLICATIONS: We studied the efficacy of ketorolac, a prostaglandin synthesis inhibitor, in the treatment of bladder spasm after ureteroneocystostomy (antireflux operation). Patients were randomized in a double-blinded manner to receive either ketorolac or placebo after the surgery. We demonstrate that ketorolac reduces the frequency and severity of postoperative bladder spasm.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Cystostomy/adverse effects , Ketorolac/therapeutic use , Postoperative Complications/prevention & control , Spasm/prevention & control , Ureterostomy/adverse effects , Urinary Bladder Diseases/prevention & control , Child , Child, Preschool , Double-Blind Method , Humans , Prospective Studies , Spasm/etiology , Urinary Bladder Diseases/etiology , Vesico-Ureteral Reflux/surgery
8.
Paediatr Anaesth ; 10(2): 133-6, 2000.
Article in English | MEDLINE | ID: mdl-10736074

ABSTRACT

The onset and time course of action of rocuronium in normal children and children receiving anticonvulsant drugs for prolonged periods was characterized. A single bolus dose of 0.6 mg.kg-1 rocuronium was administered i.v. to seven nonepileptic patients on no medication, and eight patients on chronic anticonvulsant therapy consisting of either phenytoin, carbamazepine, or both who were age and weight matched. Neuromuscular transmission was monitored by the evoked compound electromyography of the thenar muscles using train of four stimulation every 20 s. Recovery times of the first twitch to 10%, 25%, 50%, 75% and 100% of baseline values and recovery index were obtained. The onset times were 1.05+/-0.5 and 1.41+/-0.5 min for the control and anticonvulsant groups respectively and were not significantly different. Children receiving chronic anticonvulsant therapy had significantly shorter recovery index than the control group (control 10.4+/-5.1 min, anticonvulsant 4.8+/-1.7 min, P<0.05). Furthermore, the duration of recovery to 10%, 50%, 75% and 100% of baseline T1 values was less in the anticonvulsant drug group. Our data confirm resistance to rocuronium in children on chronic anticonvulsant drugs.


Subject(s)
Androstanols/administration & dosage , Anticonvulsants/therapeutic use , Neuromuscular Blockade , Neuromuscular Nondepolarizing Agents/administration & dosage , Analysis of Variance , Anesthesia Recovery Period , Carbamazepine/therapeutic use , Case-Control Studies , Child , Drug Interactions , Electric Stimulation , Electromyography/drug effects , Epilepsy/drug therapy , Evoked Potentials, Motor/drug effects , Humans , Injections, Intravenous , Muscle Contraction/drug effects , Muscle, Skeletal/innervation , Neuromuscular Junction/drug effects , Phenytoin/therapeutic use , Rocuronium , Synaptic Transmission/drug effects , Thumb/innervation , Time Factors
9.
Clin Infect Dis ; 28(5): 1156-8, 1999 May.
Article in English | MEDLINE | ID: mdl-10452652

ABSTRACT

Bartonella henselae was recovered from the conjunctival scraping of a 38-year-old woman who presented with a 2-week history of tender preauricular lymphadenopathy and a 1-day history of a red left eye. Dry adherent colonies were observed on agar plates at 21 days of incubation, and the isolate was identified through conventional and molecular tests. Polymerase chain reaction (PCR) amplification of a specific region of the 16S rRNA gene and confirmation by a separate PCR reaction with hybridization of the product with a B. henselae-specific probe confirmed the isolate as B. henselae. This is the first reported isolation of the causative agent of cat scratch disease from ocular tissue in a patient with Parinaud's oculoglandular syndrome.


Subject(s)
Bartonella henselae/isolation & purification , Cat-Scratch Disease/microbiology , Conjunctivitis, Bacterial/microbiology , Adult , Animals , Antibodies, Bacterial/blood , Bartonella henselae/genetics , Bartonella henselae/immunology , Cat-Scratch Disease/diagnosis , Cats , Conjunctivitis, Bacterial/diagnosis , Female , Humans , Immunoglobulin G/blood , Lymphatic Diseases/microbiology , Polymerase Chain Reaction
10.
Ophthalmology ; 104(9): 1402-8, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9307633

ABSTRACT

PURPOSE: Carbomer gel is a water-soluble polymeric resin that has been reported to maintain the tear film in contact with the eye for an extended period. The efficacy and safety of this new artificial tear were assessed. METHODS: A multicenter, single-masked, randomized, placebo-controlled study was carried out on 123 patients with moderate-to-severe dry eyes. The placebo was a mannitol solution with benzalkonium chloride 0.008% as preservative. Patients were observed over an 8-week period, and subjective and objective changes analyzed, compared to a baseline of no therapy, after 1 to 7 days washout period from previous medication. RESULTS: All primary subjective symptoms decreased significantly in the carbomer gel-treated group compared to the placebo group (i.e., dryness, discomfort, and foreign body sensation). The carbomer gel also significantly improved the rose bengal staining score relative to placebo. When data for the primary subjective efficacy variables were stratified for disease severity, there was a statistically significant improvement from baseline by day 10 for severely affected patients and from day 42 for patients with moderate disease. Secondary subjective symptoms that improved significantly in the tear gel group compared to placebo were photophobia, erythema, tear breakup time, blurry-filmy, dry-sandy sensation, and physician impression. However, no significant improvements in the secondary subjective symptoms of tearing, itching, scaling, conjuctival discharge, palpebral conjunctival redness, bulbar conjuctival redness, conjunctival luster, relief of discomfort, ease of use, and overall acceptability were found in either group over the baseline score. In addition, neither carbomer gel nor placebo improved the baseline fluorescein staining score or the Schirmer test score. Two patients suffered local allergic reactions to the carbomer gel or its preservative, which settled on withdrawal of the medication. CONCLUSIONS: Carbomer gel was more efficacious than was placebo in improving a number of subjective and objective symptoms of moderate-to-severe dry eye syndrome. The results of this study indicate that carbomer gel was a safe as was the placebo.


Subject(s)
Acrylic Resins/therapeutic use , Dry Eye Syndromes/drug therapy , Ophthalmic Solutions/therapeutic use , Acrylic Resins/adverse effects , Adult , Aged , Aged, 80 and over , Drug Evaluation , Dry Eye Syndromes/physiopathology , Female , Fluorescent Dyes , Gels , Humans , Male , Middle Aged , Ophthalmic Solutions/adverse effects , Placebos , Rose Bengal , Safety , Single-Blind Method , Tears/physiology , Treatment Outcome
11.
Anesthesiology ; 85(6): 1260-7, 1996 Dec.
Article in English | MEDLINE | ID: mdl-8968172

ABSTRACT

BACKGROUND: Cardiovascular stability is an important prerequisite for any new volatile anesthetic. We compared echocardiographically derived indices of myocardial contractility during inhalation induction with sevoflurane and halothane in children. METHODS: Twenty children were randomized to receive either halothane or sevoflurane for inhalation induction of anesthesia. No preoperative medications were given. Myocardial contractility was evaluated at baseline and at sevoflurane and halothane end-tidal concentrations of 1.0 minimum alveolar concentration (MAC) and 1.5 MAC. RESULTS: There were no differences between groups in patient age, sex, physical status, weight, or height. Equilibration times and MAC multiples of sevoflurane and halothane were comparable. Vital signs remained stable throughout the study. Left ventricular end-systolic meridional wall stress increased with halothane but remained unchanged with sevoflurane. Systemic vascular resistance decreased from baseline to 1 MAC and 1.5 MAC with sevoflurane. Halothane depressed contractility as assessed by the stress-velocity index and stress-shortening index, whereas contractility remained within normal limits with sevoflurane. Total minute stress and normalized total mechanical energy expenditure, measures of myocardial oxygen consumption, did not change with either agent. CONCLUSIONS: Myocardial contractility was decreased less during inhalation induction of anesthesia with sevoflurane compared with halothane in children. Although the induction of anesthesia with sevoflurane or halothane was equally well tolerated, the preservation of myocardial contractility with sevoflurane makes it an attractive alternative for inducing anesthesia in children.


Subject(s)
Anesthesia, Inhalation , Anesthetics, Inhalation/pharmacology , Ethers/pharmacology , Halothane/pharmacology , Methyl Ethers , Myocardial Contraction/drug effects , Child , Child, Preschool , Echocardiography , Female , Hemodynamics/drug effects , Humans , Male , Random Allocation , Sevoflurane
12.
Anesth Analg ; 83(2): 325-8, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8694313

ABSTRACT

Children undergoing neurosurgical resection are at high risk for postoperative nausea and vomiting. Ondansetron, a selective serotonergic (5-HT3) antagonist, is effective in reducing postoperative vomiting in several high-risk populations. In a prospective, randomized study, we compared the prophylactic use of intravenous ondansetron, 0.15 mg/kg, versus placebo for the prevention of emesis in 60 children, aged 2-18 yr, undergoing craniotomies for resective procedures. Patients with preoperative emesis were excluded from the study. All patients were tracheally extubated at the conclusion of surgery, and each episode of emesis during the first 24 postoperative hours was recorded. For the entire 24-h interval, the incidence of emesis in children who received ondansetron (57%) was not significantly different from that in those who received placebo (66%); however, in the first 8 h, the incidence was 25% (ondansetron) vs 44% (placebo) (P = not significant). In those receiving placebo, there was no difference in emesis between patients undergoing operations above versus below the tentorium. Although our sample size was too small to completely exclude any beneficial effect, ondansetron appears ineffective in preventing postoperative emesis in this patient population.


Subject(s)
Antiemetics/therapeutic use , Craniotomy , Ondansetron/therapeutic use , Postoperative Complications/prevention & control , Vomiting/prevention & control , Adolescent , Antiemetics/administration & dosage , Brain/surgery , Cerebellum/surgery , Child , Child, Preschool , Craniotomy/adverse effects , Double-Blind Method , Female , Humans , Incidence , Injections, Intravenous , Male , Nausea/prevention & control , Ondansetron/administration & dosage , Placebos , Prospective Studies , Serotonin Antagonists/administration & dosage , Serotonin Antagonists/therapeutic use , Time Factors
13.
Can J Anaesth ; 43(5 Pt 1): 461-6, 1996 May.
Article in English | MEDLINE | ID: mdl-8723852

ABSTRACT

PURPOSE: There is conflicting evidence as to whether the effect of mannitol on brain bulk arises from haemodynamic, rheologic, or osmotic mechanisms. If mannitol alters cerebral haemodynamics by inducing vasoconstriction, this change should be reflected in cerebral blood flow velocity (CBFV) in the middle cerebral artery (MCA). The purpose of this study was to evaluate the effect of mannitol on CBFV in children. METHODS: Children scheduled for intracranial surgery were enrolled. After a loading dose of 10 micrograms.kg-1 of fentanyl, general anaesthesia was maintained with fentanyl (3 micrograms.kg-1.hr-1), 66% nitrous oxide, and isoflurane (0.2-0.5% inspired). Mean and systolic CBFV (Vm and Vs) and pulsatility index (PI) were recorded with a transcranial Doppler (TCD) directed at the M1 segment of the MCA. Mannitol was administered, 1 gm.kg-1 iv over 15 min. The osmolality (Osm), haematocrit (Hct), mean arterial pressure (MAP), heart rate (HR), and TCD variables were recorded before and 15, 30, 45, and 60 min after the mannitol infusion. RESULTS: Mannitol infusion resulted in an increase in Osm and decrease in Hct (P < 0.05). Heart rate, MAP and arterial carbon dioxide tensions did not change (P > 0.05) during the measuring period. The Vm did not vary from baseline. The Vs and PI both increased briefly (P < 0.01 at 15 min and P < 0.05 at 30 min) after the mannitol, suggesting an increase in resistance distal to the MCA. CONCLUSION: The time course of CBFV changes produced by mannitol corresponds with previous animal data concerning cerebrovascular tone. Our results suggest that mannitol briefly increases cerebrovascular resistance and thereby diminishes cerebral blood volume.


Subject(s)
Cerebrovascular Circulation/drug effects , Mannitol/pharmacology , Adolescent , Brain/surgery , Child , Child, Preschool , Female , Hematocrit , Humans , Infant , Intracranial Pressure/drug effects , Male
14.
Anesth Analg ; 80(2): 226-9, 1995 Feb.
Article in English | MEDLINE | ID: mdl-7818104

ABSTRACT

The study was designed to compare intravenous ketorolac to rectal acetaminophen for analgesia and bleeding in pediatric patients undergoing tonsillectomy. We studied 50 patients, aged 2-15 yr undergoing tonsillectomy with or without adenoidectomy. In a randomized, prospective double-blind fashion, patients were assigned to receive either ketorolac (1 mg/kg) or rectal acetaminophen (35 mg/kg). Bleeding was evaluated by measuring intraoperative blood loss and noting extra measures required to obtain hemostasis. Bleeding times were also measured before and during surgery. Pain was evaluated using a standard objective pain score for the first 3 h. Persistent pain was treated with morphine, acetaminophen, and codeine and recorded for 24 h. Blood for determination of acetaminophen levels was drawn at 20 and 40 min after the administration of study drugs. Pain scores were not significantly different between the ketorolac and acetaminophen groups. The majority of patients in both groups required additional opioid in the postoperative period. Acetaminophen levels were all less than the therapeutic range. Intraoperative bleeding times were normal in all patients, but blood loss was significantly higher in the ketorolac group (2.67 mL/kg) compared to the acetaminophen group (1.44 mL/kg), P = 0.025. Significantly more measures to achieve hemostasis were required in the ketorolac group (P = 0.012). We conclude that ketorolac is no more effective than high-dose rectal acetaminophen for analgesia in the patient undergoing tonsillectomy. Hemostasis during tonsillectomy was significantly more difficult to achieve in patients receiving ketorolac.


Subject(s)
Acetaminophen , Analgesia , Analgesics, Non-Narcotic/adverse effects , Bleeding Time , Tolmetin/analogs & derivatives , Tonsillectomy , Tromethamine/analogs & derivatives , Acetaminophen/administration & dosage , Acetaminophen/blood , Adolescent , Analgesics, Non-Narcotic/administration & dosage , Analgesics, Non-Narcotic/pharmacology , Child , Child, Preschool , Double-Blind Method , Hemostasis, Surgical , Humans , Ketorolac Tromethamine , Prospective Studies , Tolmetin/administration & dosage , Tolmetin/adverse effects , Tolmetin/pharmacology , Tromethamine/administration & dosage , Tromethamine/adverse effects , Tromethamine/pharmacology
15.
Aust N Z J Ophthalmol ; 22(3): 175-81, 1994 Aug.
Article in English | MEDLINE | ID: mdl-7818875

ABSTRACT

OBJECTIVE: To report six cases of sterile inflammatory reactions to fine monofilament suture materials, which is exceedingly rare in ophthalmology. METHODS: We report six patients (four underwent penetrating keratoplasty and two underwent cataract surgery) with unusually severe local inflammatory reactions to suture material. RESULTS: Patients developed multiple focal inflammatory infiltrates and corneal oedema related to 10/0 monofilament nylon sutures. Four patients had evidence of either atopy or raised serum IgE and one had an autoimmune disorder (systemic lupus erythematosis). Onset was four to 11 days in five cases and six weeks in one. Allograft reaction occurred in two of the four corneal grafts, and three grafts failed. One of the cataract patients developed significant against-the-rule astigmatism. Microbial cultures of corneal scrapings, donor corneal rims, and suture material were generally negative. Polymorphonuclear leucocytes were noted on Gram stain in four cases, and cytology of corneal scrapings demonstrated eosinophils in one case. CONCLUSIONS: Sterile inflammatory reactions to monofilament suture material are an uncommon complication of ocular surgery which may lead to corneal graft failure, and which is more common in atopic individuals. Systemic steroid therapy may be required.


Subject(s)
Endophthalmitis/etiology , Nylons/adverse effects , Sutures , Adolescent , Adult , Astigmatism/etiology , Cataract Extraction , Endophthalmitis/pathology , Female , Graft Rejection/etiology , Humans , Keratoplasty, Penetrating , Lenses, Intraocular , Male , Middle Aged
16.
Aust N Z J Ophthalmol ; 22(3): 207-9, 1994 Aug.
Article in English | MEDLINE | ID: mdl-7818880

ABSTRACT

BACKGROUND: The fungus Scedosporium prolificans was first described as a human pathogen in 1984, and has been associated with metastatic endophthalmitis and one previously reported case of sclerokeratitis. METHODS: We report a case of S. prolificans sclerokeratitis in the setting of late scleral necrosis complicating pterygium surgery with adjunctive beta-irradiation. RESULTS: A poor clinical response to topical natamycin and amphotericin B, and systemic itraconazole and ketoconazole was encountered. Enucleation was required, with subsequent microbiological cure. Pathological correlation is described. CONCLUSIONS: S. prolificans infections often respond poorly to medical therapy. Early surgical intervention is indicated in culture-proven scleritis due to Scedosporium prolificans.


Subject(s)
Eye Infections, Fungal , Keratitis/microbiology , Mycetoma , Scleritis/microbiology , Aged , Anti-Bacterial Agents , Drug Therapy, Combination/therapeutic use , Eye Enucleation , Humans , Keratitis/drug therapy , Keratitis/pathology , Male , Necrosis/etiology , Postoperative Complications , Pterygium/radiotherapy , Pterygium/surgery , Scleritis/drug therapy , Scleritis/pathology
17.
J Neurosurg Anesthesiol ; 6(3): 153-5, 1994 Jul.
Article in English | MEDLINE | ID: mdl-8081094

ABSTRACT

Precordial ultrasonic Doppler devices are effective monitors for detecting venous air emboli (VAE). However, placing an ultrasonic probe on the anterior part of the chest of a prone patient can lead to dislodgment or pressure sores and makes the probe inaccessible to the anesthesiologist. The purpose of this study was to compare placement of a Doppler probe on the patient's back with the traditional precordial site for the ability to detect VAE. We enrolled infants and children undergoing neurosurgical procedures in the prone position in the study. After establishment of general anesthesia and endotracheal intubation, we applied an ultrasonic Doppler probe to the right sternal border of the patient's chest. Anterior insonation was performed with the patient in the supine position. Saline was rapidly injected to verify the efficacy of the monitor (injection test). The patient was turned to the prone position and we placed the Doppler probe between the right scapula and spine. Posterior insonation with saline injection was performed with the patient in the prone position. We obtained positive tests in all patients from the anterior site. Positive tests were obtained from the posterior site in 23 of 24 (96%) children < 10 kilograms (group I), 28 of 39 (72%) children between 10 and 20 kg (group II), and 6 of 22 (27%) children > 20 kilograms (group III). This study demonstrates that a posterior Doppler probe can be effective for monitoring infants at risk of VAE. However, this method is not reliable in children weighting > 10 kg.


Subject(s)
Brain/surgery , Embolism, Air/diagnostic imaging , Intraoperative Complications/diagnostic imaging , Monitoring, Intraoperative/instrumentation , Prone Position , Pulmonary Embolism/diagnostic imaging , Back , Body Weight , Child , Child, Preschool , Humans , Infant , Thorax , Ultrasonography/instrumentation
18.
J Am Vet Med Assoc ; 204(1): 94-6, 1994 Jan 01.
Article in English | MEDLINE | ID: mdl-8125828

ABSTRACT

A Doberman Pinscher contracted babesiosis after receiving a fresh blood transfusion from a Greyhound blood donor. Hypotensive shock syndrome was suspected on the basis of arterial hypotension, weakness, and pyrexia in the absence of detectable hemolysis and within hours of detection of low numbers of circulating Babesia canis organisms. Treatment with imidocarb dipropionate appears to have been effective in eliminating circulating B canis organisms and clinical disease. The blood donor, recently acquired from a race track, was healthy and lacked any abnormalities on initial laboratory evaluation; however, its serum antibody titer for B canis was > 1:5,000; B canis organisms were later identified on blood smears after the dog had been splenectomized and treated with corticosteroids at an immunosuppressive dosage. This case draws attention to a potential problem in current screening practices for infectious diseases of retired racing Greyhounds intended for use as blood donors.


Subject(s)
Babesiosis/complications , Carrier State/veterinary , Dog Diseases/etiology , Hypotension/veterinary , Shock, Septic/veterinary , Acute Disease , Animals , Babesiosis/blood , Babesiosis/drug therapy , Babesiosis/etiology , Blood Transfusion/veterinary , Carrier State/blood , Clindamycin/therapeutic use , Dog Diseases/blood , Dog Diseases/drug therapy , Dogs , Drug Therapy, Combination , Hypotension/etiology , Imidocarb/therapeutic use , Male , Shock, Septic/etiology , Transfusion Reaction
19.
Arch Ophthalmol ; 111(11): 1512-7, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8240107

ABSTRACT

OBJECTIVE: To ascertain and characterize rhodopsin gene mutations in autosomal dominant retinitis pigmentosa and to correlate these mutations with the clinical phenotypes. METHODS: DNA was extracted from leukocytes, and the rhodopsin gene was amplified and analyzed using molecular-biological methods. Clinical and electrophysiological data were collected from patient charts. RESULTS: We found a disease-causing mutation that was previously undescribed, to our knowledge, for autosomal dominant retinitis pigmentosa within codon 15 of exon 1 of the rhodopsin gene. It was a single base-pair transversion (AAT to AGT) leading to a serine-for-asparagine substitution. This altered a glycosylation site in the intradiscal portion of the rhodopsin molecule. The pedigree examined demonstrated an inferior distribution of retinal pigmentary changes and predominantly superior visual field loss with relative preservation of electroretinographic amplitudes and good vision, which is consistent with sectorial or sectorial-like retinitis pigmentosa. CONCLUSIONS: A codon 15 rhodopsin gene mutation caused retinitis pigmentosa in the pedigree studied. There may be an association between intradiscal rhodopsin gene mutations and sectorial forms of retinitis pigmentosa.


Subject(s)
Codon , Mutation/genetics , Retinitis Pigmentosa/genetics , Rhodopsin/genetics , Adult , Aged , Base Sequence , Chromosome Aberrations/genetics , Chromosome Disorders , Chromosomes, Human, Pair 3 , DNA Primers , Electroretinography , Female , Fundus Oculi , Humans , Male , Middle Aged , Molecular Sequence Data , Pedigree , Phenotype , Retinitis Pigmentosa/pathology , Retinitis Pigmentosa/physiopathology , Visual Fields
20.
J Clin Neuroophthalmol ; 11(4): 262-7, 1991 Dec.
Article in English | MEDLINE | ID: mdl-1838546

ABSTRACT

Pituitary tumors are a significant cause of visual morbidity. The medical records of 45 patients with histologically verified pituitary adenoma and visual defects (fields and/or acuity) were reviewed. The patients' ages ranged from 19 to 80 years with a mean of 52.4 years. Ophthalmologists referred 76% of the patients for neurosurgical opinion. Bitemporal field defects were present in 89%. Twenty-three patients underwent transfrontal craniotomy prior to 1984, and the remaining twenty-two subsequently had transsphenoidal microsurgery. Of those eyes with abnormal visual acuity preoperatively, 74% had improvement noted postoperatively (p less than 0.001). Of those eyes with preoperatively abnormal visual fields, 68% improved (p less than 0.001). For transsphenoidal surgery the rate of improvement for fields was 81%. Preoperative visual acuity, visual field score, and patient age, were not predictive of postoperative acuity. Optic disc pallor was associated with poorer postoperative fields and acuity compared to eyes without preoperative pallor. Transsphenoidal surgery is effective treatment for visual compromise due to pituitary adenoma, and the need for early diagnosis is emphasized.


Subject(s)
Adenoma/surgery , Pituitary Neoplasms/surgery , Vision Disorders/etiology , Adenoma/complications , Adult , Aged , Aged, 80 and over , Female , Follow-Up Studies , Humans , Male , Middle Aged , Pituitary Neoplasms/complications , Prolactinoma/complications , Prolactinoma/surgery , Retrospective Studies , Treatment Outcome , Vision Disorders/physiopathology , Visual Acuity , Visual Fields
SELECTION OF CITATIONS
SEARCH DETAIL
...